Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginEquity AverageFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on EquityReturn on SalesTimes Interest Earned

Medicale (MCLE) Return on Capital Employed (2021 - 2024)

Medicale's Return on Capital Employed history spans 4 years, with the latest figure at 2.29% for Q4 2024.

  • For Q4 2024, Return on Capital Employed fell 178.0% year-over-year to 2.29%; the TTM value through Dec 2024 reached 2.29%, down 178.0%, while the annual FY2024 figure was 3.56%, N/A changed from the prior year.
  • Return on Capital Employed reached 2.29% in Q4 2024 per MCLE's latest filing, down from 3.56% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 4.11% in Q1 2024 to a low of 0.92% in Q3 2023.
  • Average Return on Capital Employed over 4 years is 2.39%, with a median of 2.02% recorded in 2021.
  • The largest YoY upside for Return on Capital Employed was 264bps in 2024 against a maximum downside of -178bps in 2024.
  • A 4-year view of Return on Capital Employed shows it stood at 2.02% in 2021, then tumbled by -54bps to 0.92% in 2022, then skyrocketed by 341bps to 4.07% in 2023, then plummeted by -44bps to 2.29% in 2024.
  • Per Business Quant, the three most recent readings for MCLE's Return on Capital Employed are 2.29% (Q4 2024), 3.56% (Q3 2024), and 3.82% (Q2 2024).